HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takeshi Niizeki Selected Research

Diacylglycerol Kinase

1/2011Diacylglycerol kinase ΞΆ inhibits ventricular tachyarrhythmias in a mouse model of heart failure.
1/2009Diacylglycerol kinase zeta inhibits G(alpha)q-induced atrial remodeling in transgenic mice.
2/2008Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.
2/2008Diacylglycerol kinase zeta rescues G alpha q-induced heart failure in transgenic mice.
2/2007Diacylglycerol kinase zeta attenuates pressure overload-induced cardiac hypertrophy.
2/2007Cardiac-specific overexpression of diacylglycerol kinase zeta attenuates left ventricular remodeling and improves survival after myocardial infarction.
1/2006Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
3/2005Adenovirus-mediated overexpression of diacylglycerol kinase-zeta inhibits endothelin-1-induced cardiomyocyte hypertrophy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takeshi Niizeki Research Topics

Disease

22Heart Failure
12/2021 - 07/2005
14Cardiovascular Diseases (Cardiovascular Disease)
11/2010 - 07/2005
6Death (Near-Death Experience)
04/2009 - 10/2005
6Cardiomegaly (Heart Hypertrophy)
07/2008 - 10/2005
5Inflammation (Inflammations)
11/2008 - 07/2006
2Atherosclerotic Plaque (Atheroma)
02/2022 - 01/2022
2Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
04/2013 - 09/2008
2Myocardial Infarction
10/2008 - 02/2007
2Obesity
09/2007 - 04/2007
2Fibrosis (Cirrhosis)
02/2007 - 02/2007
2Renal Insufficiency (Renal Failure)
10/2005 - 10/2005
1Hemorrhage
02/2022
1Hyperuricemia
12/2021
1Fibromuscular Dysplasia
03/2015
1Atrial Fibrillation
10/2014
1Intracranial Embolism
07/2014
1Leriche Syndrome
01/2014
1Beriberi
07/2013
1Wernicke Encephalopathy (Wernicke's Encephalopathy)
07/2013
1Albuminuria
04/2013
1Ventricular Tachycardia
01/2011
1Tachycardia (Tachyarrhythmias)
01/2011
1Ventricular Premature Complexes (Premature Ventricular Contraction)
01/2011
1Atrial Remodeling
01/2009
1Left Ventricular Dysfunction
11/2008
1Atrophy
02/2008
1Diabetes Mellitus
02/2008
1Diabetes Complications
02/2008
1Insulin Resistance
04/2007
1Coronary Artery Disease (Coronary Atherosclerosis)
04/2007
1Ventricular Remodeling
02/2007
1Vascular System Injuries
07/2006
1Hypertension (High Blood Pressure)
05/2006
1Body Weight (Weight, Body)
01/2006
1Hypertrophy
03/2005

Drug/Important Bio-Agent (IBA)

8Brain Natriuretic Peptide (Natrecor)FDA Link
10/2014 - 08/2005
8Diacylglycerol KinaseIBA
01/2011 - 03/2005
8Fatty Acid Binding Protein 3IBA
11/2008 - 07/2005
6DiglyceridesIBA
01/2009 - 01/2006
5Fatty Acid-Binding ProteinsIBA
11/2008 - 07/2005
5Protein Kinase CIBA
07/2008 - 03/2005
4Uric Acid (Urate)IBA
12/2021 - 05/2006
4EnzymesIBA
03/2008 - 10/2005
3CreatinineIBA
04/2009 - 10/2005
3ImmunosorbentsIBA
03/2008 - 04/2007
3Collagen Type I (Type I Collagen)IBA
06/2007 - 02/2007
3Angiotensin IIIBA
02/2007 - 10/2005
2C-Reactive ProteinIBA
04/2009 - 01/2008
2Biomarkers (Surrogate Marker)IBA
04/2009 - 11/2008
2GTP-Binding Proteins (G-Protein)IBA
01/2009 - 02/2008
2PTX3 proteinIBA
11/2008 - 01/2008
2Proteins (Proteins, Gene)FDA Link
07/2008 - 02/2007
2pentosidineIBA
03/2008 - 04/2007
2Advanced Glycation End ProductsIBA
03/2008 - 04/2007
2Gq-G11 GTP-Binding Protein alpha Subunits (Gq Protein)IBA
02/2008 - 01/2006
2Phenylephrine (Neo-Synephrine)FDA LinkGeneric
02/2007 - 01/2006
2Collagen Type III (Type III Collagen)IBA
02/2007 - 02/2007
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2007 - 02/2007
2Atrial Natriuretic Factor (ANF)IBA
01/2006 - 03/2005
1Pharmaceutical PreparationsIBA
02/2022
1Allopurinol (Remid)FDA LinkGeneric
12/2021
1FebuxostatFDA Link
12/2021
1LDL CholesterolIBA
07/2014
1LDL Lipoproteins (beta Lipoproteins)IBA
07/2014
1LipidsIBA
07/2014
1Rosuvastatin Calcium (Crestor)FDA Link
07/2014
1oxidized low density lipoproteinIBA
07/2014
1Thiamine (Aneurin)FDA Link
07/2013
1Indicators and Reagents (Reagents)IBA
04/2013
1Polyvinyl Chloride (PVC)IBA
01/2011
1NeopterinIBA
11/2010
1SodiumIBA
04/2009
1Hemoglobins (Hemoglobin)IBA
04/2009
1HMGB1 Protein (HMG1)IBA
10/2008
1Ventricular MyosinsIBA
10/2008
1Chaperonin 60IBA
09/2008
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2008
1Receptor for Advanced Glycation End ProductsIBA
03/2008
1Streptozocin (Streptozotocin)FDA Link
02/2008
1ResistinIBA
04/2007
1Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
04/2007
1Troponin T (Troponin T1)IBA
03/2007
1Trinitrotoluene (TNT)IBA
03/2007
1CollagenIBA
02/2007
1CytokinesIBA
07/2006
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2006
1Cystatin CIBA
10/2005
1DNA (Deoxyribonucleic Acid)IBA
10/2005
1pitavastatin (itavastatin)FDA Link
10/2005
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2005

Therapy/Procedure

5Patient Readmission
11/2008 - 10/2005
3Percutaneous Coronary Intervention
02/2022 - 01/2014
3Therapeutics
12/2021 - 01/2014
1Stents
02/2022
1Intra-Aortic Balloon Pumping
01/2014
1Sympathectomy (Sympathectomies)
02/2007
1Nephrectomy
10/2005